atentherapeutics.com valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot /
BingBot /
BaiduSpider /
YandexBot /
Meta Tags
Title aTen Therapeutics An innovative biotechnology
Description Recent Home Overview Pipeline News Contact Recent News August 2022 August 2022 aTen Therapeutics awarded £282k Innovate UK grant to develop new breast cancer tre
Keywords N/A
Server Information
WebSite atentherapeutics faviconatentherapeutics.com
Host IP 160.153.129.206
Location United States
Related Websites
Site Rank
More to Explore
atentherapeutics.com Valuation
US$302,445
Last updated: 2023-05-17 14:33:25

atentherapeutics.com has Semrush global rank of 34,995,817. atentherapeutics.com has an estimated worth of US$ 302,445, based on its estimated Ads revenue. atentherapeutics.com receives approximately 34,898 unique visitors each day. Its web server is located in United States, with IP address 160.153.129.206. According to SiteAdvisor, atentherapeutics.com is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$302,445
Daily Ads Revenue US$280
Monthly Ads Revenue US$8,376
Yearly Ads Revenue US$100,505
Daily Unique Visitors 2,327
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
atentherapeutics.com. A 10800 IP: 160.153.129.206
atentherapeutics.com. NS 3600 NS Record: ns70.domaincontrol.com.
atentherapeutics.com. NS 3600 NS Record: ns69.domaincontrol.com.
atentherapeutics.com. MX 3600 MX Record: 0 atentherapeutics-com.mail.protection.outlook.com.
atentherapeutics.com. TXT 3600 TXT Record: v=spf1 include:spf.protection.outlook.com -all
HtmlToTextCheckTime:2023-05-17 14:33:25
Home Overview Pipeline News Contact Recent News August 2022 August 2022 aTen Therapeutics awarded £282k Innovate UK grant to develop new breast cancer treatment. March 2020 aTen Therapeutics relocates to new offices at 1 Lochrin Square, Fountainbridge, Edinburgh EH3 9QA. August 2019 Ian Abercrombie appointed Chief Executive Officer at aTen Therapeutics. aTen Therapeutics An innovative biotechnology company based in Edinburgh, Scotland We are developing novel therapeutic antibodies to target a fundamental control pathway associated with cancer and several other major diseases. Our technology has great potential to provide powerful new treatment options to extend and improve lives. TENSINUMAB (ATN-E11) Our lead candidate - a novel therapeutic human antibody that significantly inhibits tumour growth and prolongs survival in experimental models of cancer. info@atentherapeutics.com © aTen Therapeutics 2022. All rights reserved home overview product terms of use news contact
HTTP Headers
HTTP/1.1 302 Found
Date: Sat, 02 Apr 2022 09:03:07 GMT
Server: Apache
Location: https://www.atentherapeutics.com/
Content-Type: text/html; charset=iso-8859-1

HTTP/2 200 
last-modified: Thu, 23 Apr 2020 16:20:26 GMT
etag: "8a80094-f6b-5a3f7a0592680"
accept-ranges: bytes
content-length: 3947
vary: Accept-Encoding
content-type: text/html
date: Sat, 02 Apr 2022 09:03:07 GMT
server: Apache
atentherapeutics.com Whois Information
Domain Name: ATENTHERAPEUTICS.COM
Registry Domain ID: 2027924241_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.godaddy.com
Registrar URL: http://www.godaddy.com
Updated Date: 2018-10-31T10:58:02Z
Creation Date: 2016-05-13T15:51:20Z
Registry Expiry Date: 2022-05-13T15:51:20Z
Registrar: GoDaddy.com, LLC
Registrar IANA ID: 146
Registrar Abuse Contact Email: abuse@godaddy.com
Registrar Abuse Contact Phone: 480-624-2505
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: NS69.DOMAINCONTROL.COM
Name Server: NS70.DOMAINCONTROL.COM
DNSSEC: unsigned
>>> Last update of whois database: 2022-04-02T09:33:26Z <<<